Engineering exosomes and their application in cardiovascular field : Bibliometric analysis from 2002 to 2022
© 2023 The Authors..
Cardiovascular disease (CVD) is the leading cause of death around the world, warranting an increasing number of studies for its treatment. Among all of its therapeutical strategies, engineered exosomes are attracting growing attention due to their excellent biocompatibility, non-immunogenicity, and favorable plasticity. Despite its increasing popularity, there is yet to be a bibliometric analysis regarding the application of exosomes in CVD treatment. Therefore, the present study assessed the current trends in engineered exosomes in treating CVD by conducting a bibliometric analysis. All associated literatures published between years 2002-2022 were collected, through the Web of Science Core Collection. Our results showed that related studies robustly increased in 2020, followed by a gradual increase from 2020 to 2022, indicating that this field attracted growing attention. Additionally, we described critical network of countries, institutions, authors, top-cited references, and keywords. The present bibliometric study provides systematic observations on engineering exosomes in treating CVD, reveals potential challenges and future direction for additional studies, and may inspire more researchers to commit to investigating treatments for CVD.
| Errataetall: |
ErratumIn: Heliyon. 2023 Aug 12;9(8):e19101. - PMID 37701403 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Heliyon - 9(2023), 8 vom: 12. Aug., Seite e18809 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhang, Xiao [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bibliometrics |
|---|
| Anmerkungen: |
Date Revised 13.09.2023 published: Electronic-eCollection ErratumIn: Heliyon. 2023 Aug 12;9(8):e19101. - PMID 37701403 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.heliyon.2023.e18809 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360756689 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360756689 | ||
| 003 | DE-627 | ||
| 005 | 20231226083707.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.heliyon.2023.e18809 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1202.xml |
| 035 | |a (DE-627)NLM360756689 | ||
| 035 | |a (NLM)37576273 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhang, Xiao |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Engineering exosomes and their application in cardiovascular field |b Bibliometric analysis from 2002 to 2022 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 13.09.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a ErratumIn: Heliyon. 2023 Aug 12;9(8):e19101. - PMID 37701403 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 The Authors. | ||
| 520 | |a Cardiovascular disease (CVD) is the leading cause of death around the world, warranting an increasing number of studies for its treatment. Among all of its therapeutical strategies, engineered exosomes are attracting growing attention due to their excellent biocompatibility, non-immunogenicity, and favorable plasticity. Despite its increasing popularity, there is yet to be a bibliometric analysis regarding the application of exosomes in CVD treatment. Therefore, the present study assessed the current trends in engineered exosomes in treating CVD by conducting a bibliometric analysis. All associated literatures published between years 2002-2022 were collected, through the Web of Science Core Collection. Our results showed that related studies robustly increased in 2020, followed by a gradual increase from 2020 to 2022, indicating that this field attracted growing attention. Additionally, we described critical network of countries, institutions, authors, top-cited references, and keywords. The present bibliometric study provides systematic observations on engineering exosomes in treating CVD, reveals potential challenges and future direction for additional studies, and may inspire more researchers to commit to investigating treatments for CVD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Bibliometrics | |
| 650 | 4 | |a Cardiovascular disease | |
| 650 | 4 | |a Engineering exosomes | |
| 650 | 4 | |a Treatment | |
| 700 | 1 | |a Yang, Zijiang |e verfasserin |4 aut | |
| 700 | 1 | |a Jiang, Jizong |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, Ming |e verfasserin |4 aut | |
| 700 | 1 | |a Guan, Longfei |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Hangil |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Hongyun |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Jiahong |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Heliyon |d 2015 |g 9(2023), 8 vom: 12. Aug., Seite e18809 |w (DE-627)NLM255913095 |x 2405-8440 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2023 |g number:8 |g day:12 |g month:08 |g pages:e18809 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.heliyon.2023.e18809 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2023 |e 8 |b 12 |c 08 |h e18809 | ||